AI & Diagnostics Software in Pennsylvania

Menarini Silicon Biosystems is a clinical laboratory and diagnostic services company specializing in non-invasive biomarker detection and cell-based assays for oncology and precision medicine applications. The company is part of the Menarini Group and operates as a CLIA-certified laboratory offering proprietary circulating tumor cell (CTC) detection platforms and phenotyping services. Primary product is CELLSEARCH®, the first and only FDA-cleared actionable test for detecting and enumerating circulating tumor cells in patients with metastatic breast, prostate, and colorectal cancer, with clinical utility demonstrated in guiding therapeutic strategy and monitoring disease progression. The company also offers CELLSEARCH® Circulating Multiple Myeloma Cell Test for minimally invasive serological monitoring via blood draw, and emerging cell-based non-invasive prenatal testing (NIPT) technology for detection of fetal genomic abnormalities. Services include biomarker phenotyping, clinical laboratory testing for biopharma clinical trials, and comprehensive research support. The company serves oncology centers, biopharma sponsors, and healthcare systems requiring standardized, reliable CTC enumeration and biomarker profiling for patient stratification, treatment monitoring, and drug development. Quality and regulatory compliance are core operational principles.

Conductive Technologies Inc. (CTI) is a contract manufacturer specializing in printed electronics and biosensors for the medical device and industrial markets. Founded in 1970 and based in York, Pennsylvania, CTI operates a 110,000 sq. ft. facility with approximately 61 employees and generates $15.4 million in annual revenue. The company holds FDA compliance and ISO 13485 (medical devices) and ISO 9001 certifications, supporting full medical device project development from conception through FDA clearance. CTI's core competencies include electrochemical sensors, biosensors, flexible circuits, and membrane switches. The company manufactures disposable glucose test strips, multiplexed point-of-care diagnostic sensors, wearable devices, and biochips/microfluidics. Manufacturing capabilities include precision laser ablation, fine-line screen printing, and flexible printed circuitry with diverse inks and materials. CTI offers design innovation, development services, and post-commercialization collaboration, particularly for next-generation disposable diagnostic biosensors and Phase Zero Sensors for early-stage biochemical assay development. The structured development process ensures products meet customer requirements and market competitiveness.

TransducerWorks, founded in 2007 and part of the Vermon Group since 2018, is a U.S.-based manufacturer of custom ultrasound transducers, arrays, and probes for medical and industrial applications. The company employs 100+ engineers and manufacturing experts in Pennsylvania and delivers high-performance solutions for OEMs in diagnostics, point-of-care, interventional, veterinary, and innovation-driven medical sectors. TransducerWorks specializes in medical diagnostic probes for radiology, cardiovascular, and OB/GYN imaging, including portable and handheld (POCUS) systems for emergency and ICU use. The company also develops therapeutic ultrasound solutions for neurostimulation, neuromodulation, and targeted drug delivery, spanning focused (HIFU, LIFU) and unfocused (LIPUS) applications at frequencies above 500 kHz. Veterinary ultrasound offerings cover all species with rugged, cost-effective designs compatible with portable or cart systems. TransducerWorks operates under ISO 13485 certification with FDA compliance, RoHS and REACH adherence, ensuring precision, traceability, and regulatory alignment for medical device manufacturers and research institutions.

ClariMed, Inc. is a global regulatory and human factors consulting firm headquartered in Chadds Ford, Pennsylvania, with offices across North America and Europe. Founded in 2022, the company specializes in user-centered design, human factors engineering, and quality management solutions for medical devices, combination products, and in-vitro diagnostics. ClariMed provides comprehensive end-to-end services including user needs assessments, contextual inquiries, human factors validation testing, regulatory compliance support, Quality Management System (QMS) implementation, UI/UX design, cybersecurity solutions, and strategic advisory services. The firm's multidisciplinary team brings expertise in human factors, industrial design, biomedical engineering, psychology, and quality engineering. ClariMed is ISO 13485:2016 certified and offers flexible engagement models—project-based consulting, embedded resources, retainer, and end-to-end support—to help MedTech and pharmaceutical companies accelerate time to market while ensuring safety, efficacy, and user satisfaction.